UnitedHealth Group (NYSE: UNH) is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone through two distinct and complementary businesses. Optum delivers care aided by technology and data, empowering people, partners and providers with the guidance and tools they need to achieve better health. UnitedHealthcare offers a full range of health benefits, enabling affordable coverage, simplifying the health care experience and delivering access to high-quality care.
Bernstein analyst Lance Wilkes upgrades UnitedHealth Group (NYSE:UNH) from Market Perform to Outperform and raises the price target from $595 to $603.
Bernstein raises UnitedHealth Group (NYSE:UNH) price target from $595 to $603 Read Post »
UBS analyst Kevin Caliendo maintains UnitedHealth Group (NYSE:UNH) with a Neutral and raises the price target from $510 to $520.
UBS raises UnitedHealth Group (NYSE:UNH) price target from $510 to $520 Read Post »
UnitedHealth (NYSE:UNH) Stock Price Target Cut to $562 From $595 at JPMorgan.
UnitedHealth (NYSE:UNH) Stock Price Target Cut to $562 From $595 at JPMorgan Read Post »
Piper Sandler analyst Jessica Tassan initiates coverage on UnitedHealth Group (NYSE:UNH) with a Overweight rating and announces Price Target of $580.
Piper Sandler announced UnitedHealth Group (NYSE:UNH) Price Target of $580 Read Post »
Raymond James analyst John Ransom maintains UnitedHealth Group (NYSE:UNH) with a Strong Buy and maintains $630 price target.
Raymond James maintained UnitedHealth Group (NYSE:UNH) $630 price target Read Post »
Analyst Forecast UnitedHealth Group (NYSE:UNH) reported Q1 2023 adjusted earnings of $6.26 per diluted share, up from $5.49 per share a year earlier. Analysts polled by Capital IQ expected adjusted EPS of $6.08. Revenue for the quarter ended March 31 was $91.93 billion, up from $80.15 billion a year ago. Analysts surveyed by Capital IQ expected $89.78 billion. The company said it expects 2023 adjusted EPS of $24.50 to $25. Analysts polled by Capital IQ are projecting adjusted EPS of $24.93. Financian Revenues of $91.9 Billion, Grew 15% Year-Over-Year Earnings from Operations Grew 16% Cash Flows from Operations were $16.3 Billion; Adjusted Cash Flows from Operations were $5.1 Billion Earnings were $5.95 Per Share, Adjusted Earnings $6.26 Per Share Earnings Guidance The company increased its full year net earnings outlook to $23.25 to $23.75 per share and adjusted net earnings to $24.50 to $25.00 per share. Share Repurchase The company